Top

Published in:

01-08-2010 | Letter to the Editor

Human papillomavirus is not associated with breast carcinoma

Authors: Dilek Yavuzer, Taflan Salepci, Nimet Karadayi, Huseyin Baloglu, Zafer Kucukodaci

Published in: Breast Cancer Research and Treatment | Issue 3/2010

Excerpt

Breast cancer is the most common cancer in women, accounting for 23% of all female cancers around the world. Research on its etiology has focused primarily on genetic and environmental factors [1]. Infectious etiology in carcinogenesis has long been suggested by epidemiological and experimental studies. Current estimates suggest that approximately 15–20% of all cancers worldwide appear to be associated with viral infections, and several human DNA viruses are now accepted as causative agent of specific malignancies [2]. Human papillomavirus (HPV) is one of the viruses and is responsible for causing virtually all cases of cervical cancer in women [2]. A number of studies have reported HPV DNA detection in extragenital cancers, although the etiological involvement of HPV in those malignancies is still controversial [3]. The aim of the present study was to investigate a possible presence of HPV DNA in breast cancer tissue in a population of Turkish women and discuss the results in the light of literature. …

Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108CrossRefPubMed

Javier RT, Butel JS (2008) The history of tumor virology. Cancer Res 68(19):7693–7706CrossRefPubMed

Gillison ML, Shah KV (2003) Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 31:57–65PubMed

Di Lonardo A, Venuti A, Marcante ML (1992) Human papillomavirus in breast cancer. Breast Cancer Res Treat 21(2):95–100CrossRefPubMed

Mendizabal-Ruiz AP, Morales JA, Ramirez-Jirano LJ, Padilla-Rosas M, Moran-Moguel MC, Montoya-Fuentes H (2009) Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat 114(1):189–194CrossRefPubMed

De Villiers EM, Sandstrom RE, Zur Hausen H, Buck CE (2005) Presence of papillomavirus sequences in condylomatous lesions of the mamillae and invasive carcinoma of the breast. Breast Cancer Res 7(1):R1–R11CrossRefPubMed

Khan NA, Castillo A, Koriyama C, Kijima Y, Umetika Y, Ohi Y, Higashi M, Sagara Y, Yoshinaka H, Tsuji T, Natsugoe S, Douchi T, Eizuru Y, Akiba S (2008) Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer 99(3):408–414CrossRefPubMed

Widschwendter A, Brunhuber T, Wiedemair A, Mueller-Holzner E, Marth C (2004) Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 31(4):292–297CrossRefPubMed

De Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau X (2008) No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 109(1):55–58CrossRefPubMed

10.

Lindel K, Forster A, Altermatt HJ, Greiner R, Gruber G (2007) Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast 16(2):172–177CrossRefPubMed

11.

Milutin Gasperov N, Sabol I, Motavina M, Spaventi S, Grce M (2008) Detection and typing of human papillomaviruses combining different methods: polymerase chain reaction, restriction fragment length polymorphism, line probe assay and sequencing. Pathol Oncol Res 14(4):355–363CrossRefPubMed

12.

Inal MM, Kose S, Yildirim Y, Ozdemir Y, Toz E, Ertopçu K, Ozelmas I, Tinar S (2007) The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer 17(6):1266–1270CrossRefPubMed

13.

De Vuyst H, Clifford G, Li N, Franceschi S (2009) HPV infection in Europe. Eur J Cancer 45(15):2632–2639CrossRefPubMed

Title: Human papillomavirus is not associated with breast carcinoma
Authors: Dilek Yavuzer
Taflan Salepci
Nimet Karadayi
Huseyin Baloglu
Zafer Kucukodaci
Publication date: 01-08-2010
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 3/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-010-0963-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2010

Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis

High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation

IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls

BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer

Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall

The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures

Keynote webinar | Spotlight on antibody–drug conjugates in cancer